BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6369389)

  • 1. [Cortical hyperostoses after long-term prostaglandin E2 therapy].
    Benz-Bohm G; Emons D; Schickendantz S; Mallmann R; Redel D; Knöpfle G; Mennicken U
    Radiologe; 1984 Feb; 24(2):72-8. PubMed ID: 6369389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.
    Ueda K; Saito A; Nakano H; Aoshima M; Yokota M; Muraoka R; Iwaya T
    J Pediatr; 1980 Nov; 97(5):834-6. PubMed ID: 7000997
    [No Abstract]   [Full Text] [Related]  

  • 3. [Skeletal side effects of treatment with prostaglandin E1].
    Persigehl M; Hövels-Gürich H; von Bernuth G
    Rofo; 1984 Oct; 141(4):427-30. PubMed ID: 6436918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion.
    Kalloghlian AK; Frayha HH; deMoor MM
    Eur J Pediatr; 1996 Mar; 155(3):173-4. PubMed ID: 8929722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease.
    Høst A; Halken S; Andersen PE
    Pediatr Radiol; 1988; 18(2):149-53. PubMed ID: 3281113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone formation induced in an infant by systemic prostaglandin-E2 administration.
    Jørgensen HR; Svanholm H; Høst A
    Acta Orthop Scand; 1988 Aug; 59(4):464-6. PubMed ID: 3166573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widening of cranial sutures after long-term prostaglandin E2 therapy in two newborn infants.
    Hoevels-Guerich H; Haferkorn L; Persigehl M; Hofstetter R; von Bernuth G
    J Pediatr; 1984 Jul; 105(1):72-4. PubMed ID: 6588182
    [No Abstract]   [Full Text] [Related]  

  • 8. Resolution of prostaglandin-induced cortical hyperostosis in an infant.
    Alpert BS; Jureidini SB; Vanderzalm T
    South Med J; 1984 Aug; 77(8):1039-40. PubMed ID: 6540475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical hyperostosis after administration of prostaglandin E.
    Dekel S; Francis MJ
    J Pediatr; 1981 Sep; 99(3):500-1. PubMed ID: 7021785
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of oral and low dose intravenous prostaglandin E2 in management of ductus dependent congenital heart disease.
    Silove ED; Roberts DG; de Giovanni JV
    Arch Dis Child; 1985 Nov; 60(11):1025-30. PubMed ID: 3865636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of recurrent Caffey's disease treated with naproxen.
    Thometz JG; DiRaimondo CA
    Clin Orthop Relat Res; 1996 Feb; (323):304-9. PubMed ID: 8625597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe prenatal infantile cortical hyperostosis (Caffey's disease).
    Turnpenny PD; Davidson R; Stockdale EJ; Tolmie JL; Sutton AM
    Clin Dysmorphol; 1993 Jan; 2(1):81-6. PubMed ID: 8298744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical hyperostosis secondary to prostaglandin E1 therapy.
    Estes K; Nowicki M; Bishop P
    J Pediatr; 2007 Oct; 151(4):441, 441.e1. PubMed ID: 17889087
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prostaglandin E2 in newborns with congenital heart disease].
    Schlemmer M; Khoss A; Salzer HR; Wimmer M
    Z Kardiol; 1982 Jul; 71(7):452-7. PubMed ID: 6958133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial aspects of Caffey's disease.
    Bernstein RM; Zaleske DJ
    Am J Orthop (Belle Mead NJ); 1995 Oct; 24(10):777-81. PubMed ID: 8593560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E1 for infants with congenital heart disease.
    Sasso SC
    MCN Am J Matern Child Nurs; 1983; 8(1):29. PubMed ID: 6401340
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostaglandin E1 treatment for neonatal heart defects.
    Carey BE
    Dimens Crit Care Nurs; 1982; 1(5):275-83. PubMed ID: 6922785
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of prostaglandin E1 and E2 in the management of neonatal heart disease.
    Olley PM; Coceani F; Rowe RD
    Adv Prostaglandin Thromboxane Res; 1978; 4():345-53. PubMed ID: 645511
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiologic case study. Prostaglandin induced cortical hyperostosis.
    Parker S; Griffiths HJ
    Orthopedics; 1990 Feb; 13(2):240, 243-4. PubMed ID: 2408026
    [No Abstract]   [Full Text] [Related]  

  • 20. Infantile cortical hyperostosis (Caffey's disease). Two case reports.
    Rethmeier JW
    Radiol Clin (Basel); 1976; 45(2-4):251-7. PubMed ID: 781725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.